Family · Pharmaceutical analytical standards
Dofetilide
A class III antiarrhythmic that selectively blocks a potassium current in the heart (IKr), approved in 1999 in the United States and in Europe to restore and maintain normal rhythm in atrial fibrillation and flutter. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In Europe it left the scene in 2004, when its authorisation was voluntarily withdrawn for commercial reasons, only five years after approval.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
